Physician profile
Kyle Y Long
NPI 1609814391
$3,697.48
in general payments reported to CMS, 2019-2025
15 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $77.60 · 2021: $476 · 2022: $716 · 2023: $634 · 2024: $430 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.75 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $676.38 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Neurocrine Biosciences, INC. | $510.59 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $490.21 | 2019-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Abbvie INC. | $471.09 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $455.27 | 2019-2024 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $371.20 | 2019-2024 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $330.97 | 2019-2024 | Fanapt, Hetlioz |
| Lundbeck LLC | $88.57 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.79 | 2021-2024 | Caplyta |
| Sunovion Pharmaceuticals INC. | $61.63 | 2022 | |
| Axsome Therapeutics, INC. | $53.53 | 2023 | Auvelity |
| Noven Therapeutics, LLC | $36.67 | 2022 | |
| Indivior INC. | $34.98 | 2023-2024 | Sublocade, Perseris |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2024 | Cobenfy |
| Allergan, INC. | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.